Malaysia · Delayed Price · Currency is MYR Bioalpha Holdings Berhad Statistics
Total Valuation
KLSE:BIOHLDG has a market cap or net worth of MYR 14.20 million. The enterprise value is 265,240.
| Market Cap | 14.20M |
| Enterprise Value | 265,240 |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:BIOHLDG has 1.42 billion shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 1.42B |
| Shares Outstanding | 1.42B |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +9.79% |
| Owned by Insiders (%) | 15.50% |
| Owned by Institutions (%) | 25.70% |
| Float | 762.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.47 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.61 |
| Interest Coverage | -147.76 |
Financial Efficiency
Return on equity (ROE) is -27.65% and return on invested capital (ROIC) is -46.19%.
| Return on Equity (ROE) | -27.65% |
| Return on Assets (ROA) | -24.25% |
| Return on Invested Capital (ROIC) | -46.19% |
| Return on Capital Employed (ROCE) | -49.41% |
| Weighted Average Cost of Capital (WACC) | 6.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.79 |
Taxes
| Income Tax | -3.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 0.58, so KLSE:BIOHLDG's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 42.46 |
| Average Volume (20 Days) | 373,255 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:BIOHLDG had revenue of MYR 10.93 million and -19.84 million in losses. Loss per share was -0.02.
| Revenue | 10.93M |
| Gross Profit | 735,249 |
| Operating Income | -33.15M |
| Pretax Income | -23.98M |
| Net Income | -19.84M |
| EBITDA | -31.21M |
| EBIT | -33.15M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 16.69 million in cash and 3.73 million in debt, with a net cash position of 12.96 million or 0.01 per share.
| Cash & Cash Equivalents | 16.69M |
| Total Debt | 3.73M |
| Net Cash | 12.96M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 64.12M |
| Book Value Per Share | 0.05 |
| Working Capital | 16.66M |
Cash Flow
In the last 12 months, operating cash flow was -1.97 million and capital expenditures -354,564, giving a free cash flow of -2.32 million.
| Operating Cash Flow | -1.97M |
| Capital Expenditures | -354,564 |
| Depreciation & Amortization | 1.94M |
| Net Borrowing | -823,358 |
| Free Cash Flow | -2.32M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 6.73%, with operating and profit margins of -303.36% and -181.61%.
| Gross Margin | 6.73% |
| Operating Margin | -303.36% |
| Pretax Margin | -219.45% |
| Profit Margin | -181.61% |
| EBITDA Margin | -285.62% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KLSE:BIOHLDG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -139.79% |
| FCF Yield | -16.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 6, 2016. It was a forward split with a ratio of 1.0117668484.
| Last Split Date | Dec 6, 2016 |
| Split Type | Forward |
| Split Ratio | 1.0117668484 |
Scores
KLSE:BIOHLDG has an Altman Z-Score of -0.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.23 |
| Piotroski F-Score | 3 |